Kevin Jennings, a former nonprofit leader and Obama official, plans to expand the museum’s reach through virtual and augmented reality.
NYS Entity Status
NYS Filing Date
JUNE 30, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - EAST SIDE DEVELOPMENT GROUP LLC
AROUND THE WEB
- Tenement Museum in New York Names Its New President
By JOSHUA BARONE - Wednesday Jun 14, 2017
- A Deep Dive Into New York's East Side Access Project
Sunday Apr 24, 2016
The East Side Access project will link the Long Island Railroad to New York City's Grand Central Terminal. Projected to be completed in 2022, it required construction of about eight miles' worth of tunneling in Manhattan and Queens. Photo: Denise Blostein/The Wall Street Journal
- The Hunt: A Private Roof Deck on the Upper West Side
By JOYCE COHEN - Thursday Jun 8, 2017
A couple wanted outdoor space, and found it, but at the top of a walk-up building.
- Park Avenue Home Sells for $26 million---26% Off
Friday Jun 23, 2017
On the Upper East Side, the unit originally sought $35 million in February.
- NYU Hospital Scorched in Fire
Wednesday Dec 14, 2016
A construction site at NYU Langone Medical Center on Manhattan's east side went up in flames on Wednesday. Aerial video from the scene shows black smoke billowing into the air. Photo: WNYW
- Debt Collector Accused Of Taking Money From People Who Didn’t Owe Anything
By Ashlee Kieler - Friday Jun 23, 2017
As part of its ongoing efforts to crack down on unscrupulous debt collectors, the Federal Trade Commission has accused a North Carolina company of running a “phantom” debt collection scheme that went after people for money that they did not actually owe.The FTC announced today that it had filed a complaint accusing ACDI Group LLC and Solutions to Portfolios …
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
- Protagonist, Janssen Ink Development Deal for Crohn’s Disease Drug
By Frank Vinluan - Tuesday May 30, 2017
Protagonist Therapeutics’ work developing an inflammatory bowel disease drug that can be taken as a pill, rather than injected, now has fresh cash and the backing of a large pharmaceutical partner. Newark, CA-based Protagonist (NASDAQ: PTGX) has entered a partnership with Janssen Biotech to develop and commercialize its drug, PTG-200. Janssen is paying Protagonist $50 […]